Clinical Trial

Skin Cancer and Hyperthermia and Radiotherapy

Study acronym: SAHARA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 15, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The SAHARA trial assesses wether combining ultrahypofractionated accelerated radiotherapy (RT) with hyperthermia is as effective as standard hypofractionated high-dose radiation in treating non-melanoma skin cancer (NMSC).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-22.
Status change: Not Yet Recruiting → Recruiting 2025-06-11
Trial Details
NCT Number NCT06384053
Lead Sponsor Kantonsspital Winterthur KSW
Collaborators: Luzerner Kantonsspital, Lindenhofgruppe AG, Kantonsspital Aarau
Conditions Basal Cell Carcinoma, Squamous Cell Carcinoma Skin, Non-melanoma Skin Cancer
Enrollment 100 participants
Start Date 2025-01-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-15